DHHS Adult ARV Guidelines
Interaction Color Code
Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 2
Mechanism
Inhibition of CYP3A4 by lenacapavir
Clinical Effects
Potential increased risk of lumefantrine adverse effects
Management
If coadministering, monitor for lumefantrine adverse effects (e.g. QT prolongation)
Info Source
